We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRLD icon
2976
Prelude Therapeutics
PRLD
$390M
– –
-29,315
Closed -$1.27M
PRLB icon
2977
Protolabs
PRLB
$2.13B
– –
-4,812
Closed -$586K
PRPH
2978
DELISTED
ProPhase Labs
PRPH
– –
-5,075
Closed -$375K
PRQR icon
2979
ProQR Therapeutics
PRQR
$265M
– –
-317,705
Closed -$2.1M
PRTA icon
2980
Prothena Corp
PRTA
$450M
– –
-23,553
Closed -$591K
P
2981
Everpure Inc
P
$29.9B
– –
-235,103
Closed -$5.06M
PSTL
2982
Postal Realty Trust
PSTL
$699M
– –
-26,437
Closed -$454K
PTC icon
2983
PTC
PTC
$16B
– –
-7,056
Closed -$971K
PTGX icon
2984
Protagonist Therapeutics
PTGX
$9.44B
– –
-86,691
Closed -$2.25M
PWR icon
2985
Quanta Services
PWR
$101B
– –
-117,783
Closed -$10.4M
PXLW icon
2986
Pixelworks
PXLW
$41.6M
– –
-3,411
Closed -$135K
PZZA icon
2987
Papa John's
PZZA
$806M
– –
-11,625
Closed -$1.03M
HTT
2988
High Templar Tech Ltd
HTT
$391M
– –
-763,664
Closed -$1.74M
QFIN icon
2989
Qfin Holdings
QFIN
$1.61B
– –
-62,128
Closed -$1.62M
QQQ icon
2990
CALL
Invesco QQQ Trust
QQQ
$481B
– –
-247,200
Closed -$78.9M
QQQ icon
2991
Invesco QQQ Trust
QQQ
$481B
– –
-20,410
Closed -$6.86M
RBBN icon
2992
Ribbon Communications
RBBN
$383M
– –
-18,082
Closed -$148K
RCL icon
2993
CALL
Royal Caribbean
RCL
$85.6B
– –
-12,300
Closed -$1.05M
RCL icon
2994
Royal Caribbean
RCL
$85.6B
– –
-1,016,418
Closed -$87M
RCMT icon
2995
RCM Technologies
RCMT
$208M
– –
-11,428
Closed -$41K
RCUS icon
2996
Arcus Biosciences
RCUS
$3.64B
– –
-137,283
Closed -$3.85M
REI icon
2997
Ring Energy
REI
$339M
– –
-313,051
Closed -$723K
REXR icon
2998
Rexford Industrial Realty
REXR
$8.19B
– –
-103,795
Closed -$5.23M
REYN icon
2999
Reynolds Consumer Products
REYN
$5.59B
– –
-109,703
Closed -$3.27M
RGA icon
3000
Reinsurance Group of America
RGA
$16.1B
– –
-23,676
Closed -$2.98M
118 119
120
121 122

Similar funds

VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.